Features, pricing, ratings, and pros & cons — compared head-to-head.
Ivanti Neurons for App Control is a commercial endpoint protection platform tool by Ivanti. ThreatLocker Application Allowlisting is a commercial endpoint protection platform tool by threatlocker. Compare features, ratings, integrations, and community reviews side by side to find the best endpoint protection platform fit for your security stack.
Based on our analysis of NIST CSF 2.0 coverage, core features, integrations, company size fit, here is our conclusion:
Ivanti Neurons for App Control
Mid-market and enterprise teams drowning in unauthorized application execution and privilege creep will get real value from Ivanti Neurons for App Control because its ownership-based rules tied to NTFS security actually stick without constant tuning. The cloud-native audit-then-enforce workflow means you can test configurations against your real endpoint population before locking anything down, which beats the guess-and-patch cycle of traditional allowlisting. Skip this if your priority is behavioral threat detection; Ivanti owns access control and privilege elevation tracking (NIST PR.AA and PR.PS), not anomaly hunting.
ThreatLocker Application Allowlisting
SMBs and mid-market shops drowning in Shadow IT will see immediate payoff from ThreatLocker Application Allowlisting because deny-by-default blocks unauthorized software before it runs, no signatures required. The Learning Mode automatically catalogs your actual application estate, cutting the usual weeks of manual policy creation down to days. Skip this if your team lacks the bandwidth to manage user access request workflows or if you need detection-heavy threat hunting; ThreatLocker prioritizes prevention and asset control over post-breach forensics.
Application control and privilege management for endpoint security
Application allowlisting that blocks unauthorized software by default
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing Ivanti Neurons for App Control vs ThreatLocker Application Allowlisting for your endpoint protection platform needs.
Ivanti Neurons for App Control: Application control and privilege management for endpoint security. built by Ivanti. Core capabilities include Trusted ownership-based application control using NTFS security, Privilege management for application-specific admin rights elevation, Granular allow and deny rules for application access control..
ThreatLocker Application Allowlisting: Application allowlisting that blocks unauthorized software by default. built by threatlocker. Core capabilities include Deny-by-default application control, Learning Mode for automatic application cataloging, User access request and approval workflow..
Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.
Ivanti Neurons for App Control differentiates with Trusted ownership-based application control using NTFS security, Privilege management for application-specific admin rights elevation, Granular allow and deny rules for application access control. ThreatLocker Application Allowlisting differentiates with Deny-by-default application control, Learning Mode for automatic application cataloging, User access request and approval workflow.
Ivanti Neurons for App Control is developed by Ivanti. ThreatLocker Application Allowlisting is developed by threatlocker. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.
Ivanti Neurons for App Control and ThreatLocker Application Allowlisting serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools, both cover Ransomware Prevention. Review the feature comparison above to determine which fits your requirements.
Get strategic cybersecurity insights in your inbox